These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 26213469)
1. Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles. Naeem M; Cao J; Choi M; Kim WS; Moon HR; Lee BL; Kim MS; Jung Y; Yoo JW Int J Nanomedicine; 2015; 10():4565-80. PubMed ID: 26213469 [TBL] [Abstract][Full Text] [Related]
2. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy. Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440 [TBL] [Abstract][Full Text] [Related]
3. Enzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon. Naeem M; Kim W; Cao J; Jung Y; Yoo JW Colloids Surf B Biointerfaces; 2014 Nov; 123():271-8. PubMed ID: 25266978 [TBL] [Abstract][Full Text] [Related]
4. pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions. Naeem M; Oshi MA; Kim J; Lee J; Cao J; Nurhasni H; Im E; Jung Y; Yoo JW Nanomedicine; 2018 Apr; 14(3):823-834. PubMed ID: 29353017 [TBL] [Abstract][Full Text] [Related]
5. pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Biopharm; 2009 May; 72(1):1-8. PubMed ID: 19348015 [TBL] [Abstract][Full Text] [Related]
6. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases. Ali H; Weigmann B; Neurath MF; Collnot EM; Windbergs M; Lehr CM J Control Release; 2014 Jun; 183():167-77. PubMed ID: 24685705 [TBL] [Abstract][Full Text] [Related]
7. Budesonide-Loaded Eudragit S 100 Nanocapsules for the Treatment of Acetic Acid-Induced Colitis in Animal Model. Qelliny MR; Aly UF; Elgarhy OH; Khaled KA AAPS PharmSciTech; 2019 Jun; 20(6):237. PubMed ID: 31243601 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis. Ferri D; Costero AM; Gaviña P; Parra M; Merino V; Teruel AH; Sancenón F; Martínez-Máñez R Int J Pharm; 2019 Apr; 561():93-101. PubMed ID: 30817986 [TBL] [Abstract][Full Text] [Related]
9. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis. Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis. Zhou H; Qian H Drug Des Devel Ther; 2018; 12():2601-2609. PubMed ID: 30174414 [TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats. Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795 [TBL] [Abstract][Full Text] [Related]
12. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. Rodriguez M; Antúnez JA; Taboada C; Seijo B; Torres D J Pharm Pharmacol; 2001 Sep; 53(9):1207-15. PubMed ID: 11578103 [TBL] [Abstract][Full Text] [Related]
13. Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases. Sun Q; Luan L; Arif M; Li J; Dong QJ; Gao Y; Chi Z; Liu CG Carbohydr Polym; 2018 Jun; 189():352-359. PubMed ID: 29580419 [TBL] [Abstract][Full Text] [Related]
14. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging. Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953 [TBL] [Abstract][Full Text] [Related]
15. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis. Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772 [TBL] [Abstract][Full Text] [Related]
16. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806 [TBL] [Abstract][Full Text] [Related]
17. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy. Lale SV; R G A; Aravind A; Kumar DS; Koul V Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987 [TBL] [Abstract][Full Text] [Related]
18. Budesonide-Loaded Hyaluronic Acid Nanoparticles for Targeted Delivery to the Inflamed Intestinal Mucosa in a Rodent Model of Colitis. Vafaei SY; Abdolghaffari AH; Mahjub R; Eslami SM; Esmaeili M; Abdollahi M; Atyabi F; Dinarvand R Biomed Res Int; 2022; 2022():7776092. PubMed ID: 36203483 [TBL] [Abstract][Full Text] [Related]
19. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease. Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis. Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]